NCT00208429

Brief Summary

The purpose of this study is to monitor the performance of the Pinnacle™ Cup with a polyethylene-on-metal bearing combination in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2004

Longer than P75 for phase_4 rheumatoid-arthritis

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

June 28, 2017

Status Verified

June 1, 2017

Enrollment Period

5 years

First QC Date

September 13, 2005

Last Update Submit

June 27, 2017

Conditions

Keywords

HipCementless

Outcome Measures

Primary Outcomes (1)

  • Kaplan-Meier survivorship calculated at the five-year time-point.

    5 yrs post surgery

Secondary Outcomes (3)

  • Change in Baseline to post-operative assessment in clinical outcome using the Harris Hip Score

    6mths, 1yr, 2yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery

  • Change in Baseline to post-operative assessment in clinical outcome using the Oxford Hip Score

    Annually up to 15 yrs post-surgery

  • Kaplan-Meier survivorship

    Annually up to 15 yrs post-surgery

Study Arms (1)

Pinnacle Acetabular System

OTHER
Device: Pinnacle Acetabular System

Interventions

Pinnacle Acetabular System

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • i) Male or female subjects, aged between 18 and 70 years inclusive.
  • ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
  • iii) Subjects who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • iv) Subjects undergoing primary total hip replacement who are suitable for a cementless acetabular component and a metal on polyethylene bearing.

You may not qualify if:

  • i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
  • ii) Subjects undergoing revision hip replacement.
  • iii) Subjects undergoing simultaneous bilateral hip operation.
  • iv) Subjects with a contralateral hip replacement, which was implanted less than six months previously or is not performing satisfactorily.
  • v) Women who are pregnant.
  • vi) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes.
  • vii) Subjects who have participated in a clinical study with an investigational product in the last 12 months.
  • viii) Subjects who are currently involved in any injury litigation claims.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Arthritis, RheumatoidOsteoarthritisCollagen DiseasesOsteonecrosisHip Dislocation, CongenitalSlipped Capital Femoral Epiphyses

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsDevelopmental Dysplasia of the HipMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesOsteochondrodysplasiasBone Diseases, DevelopmentalEpiphyses, Slipped
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

July 1, 2004

Primary Completion

July 1, 2009

Study Completion

July 1, 2019

Last Updated

June 28, 2017

Record last verified: 2017-06